$5.860
-0.040 (-0.68%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GYRE por análisis de gráficos similares
Alphio's GYRE stock price prediction model matches the current Gyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.83 (-0.47%). The 1-week path is $5.85 (-0.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Gyre Therapeutics Inc?
Gyre Therapeutics is not a good buy right now due to significant financial challenges and poor technical indicators. The current price is $6.08, and the RSI is at a very low 18.42, indicating oversold conditions. Additionally, the stock has seen a 13.64% decline over the last five days and a staggering 27.10% drop over the past year, reflecting ongoing struggles. The main risk is the company's widening net loss, which reached $11.66 million in Q2 2026, a 472% increase from the previous year, raising concerns about its profitability and sustainability.
GYRE cerró en $5.86 el Thursday, tras bajar -0.68%
Gyre Therapeutics Inc (GYRE) last closed at $5.86, losing -0.68%. These facts feed the 1-day and 1-week GYRE price prediction above.
Factores de la previsión
Los factores de la previsión de Gyre Therapeutics Inc (GYRE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GYRE, ordenadas por similitud.
Análisis de estacionalidad de GYRE
Historically the probability of a positive October return for GYRE is 11.11%. February offers the highest probability of a positive month at 46.55%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.